Flatiron Health

Announced today: Flatiron Health's VALID Framework sets new methodological benchmark for data integrity in oncology research. Published in American Society of Clinical Oncology (ASCO)'s JCO CCI, Flatiron’s VALID Framework ensures LLM-extracted real-world data quality is transparent and measurable—enabling trusted, decision-ready intelligence. Flatiron's LLM-extracted data builds on the highest-quality, human-abstracted real-world data. By combining AI with expert human abstraction, Flatiron delivers gold-standard data quality at scale—enabling the evidence needed to power the highest-stakes decisions in cancer care and drug development Learn more in today’s announcement: https://lnkd.in/ed94iDgk

Join the Flatiron team at booth #500 at the upcoming Community Oncology Alliance Conference to take a closer look at the latest solutions in Flatirons point of care technology. We’ll be demoing new solutions to streamline workflows, strengthen practice operations and elevate patient care. And be sure to attend the session, The Quality of Community Oncology: Presenting the COA Quality & Value Study, where Flatiron’s Cleo A. Ryals, PhD, will present initial findings from a landmark collaboration between COA and Flatiron. Swing by during the networking breaks, or use the link below to schedule time with us in advance. ⤵️ See you in Orlando! #COA2026 https://lnkd.in/eSw_9tze

“We can no longer really rely solely on the idealized evidence that is generated from clinical trials; we need sophisticated real-world evidence that can focus on navigating the delivery of care and identifying high-risk disease among patients.” Ashwini Shewade and a panel of experts joined our recent webinar and shared their perspective on the value of #RWE in blood cancers. Watch the full webinar today: ⏯️ How breakthrough RWE is powering a new era of blood cancer research https://lnkd.in/eR4kvcrz

“Real-world evidence can help to unlock all the additional factors that you’re not going to be able to feasibly tease out in a traditional clinical trial setting” As bispecifics and CAR-T therapies reshape hematology treatment, understanding real-world utilization, outcomes, and patient barriers is essential—not optional. We recently hosted a webinar exploring how real-world evidence is powering a new era in blood cancer research. Watch the full recording to hear directly from clinical leaders and industry partners on what's actually possible when you combine comprehensive data, AI, and clinical depth. https://lnkd.in/eR4kvcrz

The Flatiron Health Point of Care team is heading to Orlando for the Community Oncology Alliance conference later this month! Stop by booth #500 to meet with our team and get a closer look at what's new in Flatiron's point of care suite. We’ll be demoing new solutions to streamline workflows, strengthen practice operations and elevate patient care, including: - End-to-end precision medicine: from ordering the right genomic tests, to receiving results, to taking action for your patients - New solutions for specialists: including the workflows supporting your procedure-based specialists today, and new features to enhance the specialist experience - AI-powered clinical and operational innovation: AI solutions enhancing your point of care workflows, with a look at what’s ahead Swing by during the networking breaks, or use the link below to schedule time with us in advance. ⤵️ See you in Orlando! #COA2026 https://lnkd.in/eqsAsCHc

“We’re starting to see, especially at Flatiron, the use of machine learning extracted options…and I think that’s going to be a game changer in terms of the scale of data we can provide.” Hear more from Senior Medical Director and International Clinical Lead, Arun Sujenthiran MD, on how LLMs are unlocking the untapped potential of RWE and how the VALID framework is ensuring AI-extracted insights continue to meet Flatiron’s gold-standard quality expectations. Read more in JCO CCI: https://lnkd.in/eTa9644r

We're coming to #SGO2026 with something we feel matters: #RWD on ovarian cancer that reflects the complexity clinicians see every day. Our Panoramic dataset spans 29,000+ patients with the biomarker details and outcomes data researchers need to answer hard questions about treatment sequencing, patient risk, and how targeted therapies truly perform. We’ll be onsite we're sharing new research on the cumulative effect of various risks in a real-world settings—demonstrating how our Panoramic data can improve understanding how real-world patient outcomes compare to results seen in randomized clinical trials. 🎬 Check out the video with Senior Clinical Director Prakirthi Yerram to learn more ⬇️

Proud to see Flatiron CTO, Allison Candido, join leaders across the life sciences ecosystem and share what it really takes to lead through AI transformation in healthcare during an Amazon Web Services (AWS)-hosted Women in GenAI event as a part of Women’s History Month. From building scalable data infrastructure to ensuring rigorous validation, the conversation made one thing clear: as AI accelerates, trust in the data behind it matters more than ever. At Flatiron Health, we believe the future of oncology depends on turning complexity into decision-ready intelligence—so researchers, clinicians, and partners can answer oncology’s most critical questions with confidence. Thank you to the organizers and fellow panelists for a powerful and honest discussion—and to the community of women leaders pushing this work forward.

#RWE informs research on more representative patient groups —including those not traditionally included in clinical trials. In this conversation, Flatiron’s International Clinical Lead, Arun Sujenthiran MD shares his perspective on the opportunity provided by #RWE and how #AI will continue to increase its scale and impact. ⏯️ Hear more:

As treatment sequencing becomes more complex due to the rising number of available therapies, #RWD can fill critical evidence gaps in understanding treatment patterns and longitudinal outcomes across diverse patient populations. Kim Saverno, shared her perspective on the value of #RWD for hematology research in our recent webinar, “How breakthrough #RWE is powering a new era of blood cancer research.” ⏯️ Watch the full webinar now: https://lnkd.in/eR4kvcrz